glp-1 stock Novo Nordisk Drops Hims & Hers: Inside the Compounded Crisis GLP-1 Agonists May Help People
Description
doi: 10.1002/ptr.8026, PMID: [DOI] [PubMed] [Google Scholar] 53
Vikrant Shrotriya, Managing Director of Novo Nordisk India, emphasized the urgent need for innovative treatment options with proven results for sustained weight loss
2022;387(3):205-216 (SURMOUNT-1)
Everyone wins when there are good options for all tastes
Pharmaceutical manufacturers learned the lesson and did a better job of testing newer formulations
Whilst obesity itself is a recognised risk factor for fertility problems, the relationship between weight loss medications and reproductive health requires careful consideration
